Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6 Month, Prospective, Randomized, Double Blind, Placebo-Controlled, Parallel Group, Multiple Center Trial To Evaluate The Efficacy And Safety Of Fragmin In The Treatment Of Chronic Neuroischaemic Foot Ulcers In Diabetic Patients

NCT00662831 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00662831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00662831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6 Month, Prospective, Randomized, Double Blind, Placebo-Controlled, Parallel Group, Multiple Center Trial To Evaluate The Efficacy And Safety Of Fragmin In The Treatment Of Chronic Neuroischaemic Foot Ulcers In Diabetic Patients
Lead sponsor
Pfizer
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2008
Completion date
October 31, 2010
Enrollment
276 (actual)
Sites
63

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer